By the quality of evidence, thymosin alpha-1 has the most clinical research (and is approved in some other countries for immune-related uses), KPV has compelling but mostly preclinical data for gut inflammation, and BPC-157 has broad animal evidence across multiple systems
Discover alternatives in sync with your needs, budget and values
the mandelate pathway allowing bacteria to use mandelic acid as a carbon source
KPV is primarily discussed for inflammation signaling and gut-related immune research, while BPC-157 is often discussed in tissue repair and healing contexts
So I think when you look at master, master, so we know what drives, so, over the last 20 years we now know the genomics of aging and Peter Attia gets into that in detail in his good book, in his longevity book, and get into the pathways that are fundamental, right